Why we should exercise ? and why we avoid it Buffalo News, United States - Nov 18, 2008 It seems to be, and on several fronts: breast, colon, endometrial, perhaps ovarian. The effect of physical activity on breast cancer prevention may be ...
Drugs you can't have Stuff.co.nz, New Zealand - Nov 30, 2008 It is a drug that, when used in a 12-month course of treatment, can help fight off breast cancer in women, but Pharmac believes a nine-week course may be ...
The angry breast cancer survivors Macleans.ca, Canada - Nov 20, 2008 Breast cancer awareness month, also known as October, came and went with scant attention paid to a new, groundbreaking book: After the Cure: The Untold ...
Advancing health benefits are a reason for us to give thanks Aiken Standard (subscription), SC - Nov 25, 2008 Thus, as an example, breast cancer continues to flourish but its death toll continues to shrivel. Thus we now joyously and thankfully see several million ...
Group therapy may extend lives of breast cancer patients TheMedGuru, India - Nov 17, 2008 All the participants were either in Stage II or Stage III of their cancer and the therapy sessions began after the women had breast cancer surgery but ...
Source: Google News
Recent News and Articles on the Keywords: supplements + 0.29 + decline Related to the article below (Last Update: 8/5/2008)
United Online Reports Second-Quarter Results Trading Markets (press release), CA - Investors and stockholders are urged to read the proxy statement/prospectus and Registration Statement, and any and all amendments or supplements thereto, ...UNTD - FTD
LodgeNet Reports Results for Second Quarter 2008 MarketWatch - Jul 29, 2008 To supplement our consolidated financial statements presented in accordance with accounting principles generally accepted in the United States ("GAAP"), ...LNET - WAR:CFL
Millipore Reports Second Quarter 2008 Financial Results MarketWatch - Jul 31, 2008 The non-GAAP financial measures are meant to supplement, and to be viewed in conjunction with, GAAP financial measures. Investors are encouraged to review ...MIL
JDA Reports Financial Results for Second Quarter 2008 WELT ONLINE, Germany - Jul 28, 2008 In evaluating the Company?s performance, management uses certain non-GAAP financial measures to supplement consolidated financial statements prepared under ...JDAS
IBERIABANK Corporation Reports Improved Credit Quality PR Newswire (press release), NY - Jul 22, 2008 The Company has prepared a PowerPoint presentation that supplements information contained in this press release. The PowerPoint presentation may be accessed ...IBKC
Fruit and vegetable consumption and cognitive decline in aging women - JH Kang, A Ascherio, F Grodstein - Annals of Neurology, 2005 - doi.wiley.com ... habits, with greater use of vitamin supplements and postmenopausal ... difference in
ini- tial score and decline in score ... 0.04 ( 0.07 to 0.004) 0.15 ( 0.29 to 0.0001 ...
Lipid-lowering effect of 2 dosages of a soy protein supplement in Hypercholesterolemia - LH H?ie, HJ Graubaum, A Harde, J Gruenwald, KD … - Advances in Therapy, 2005 - Springer ... study, participants received their nutri- tional supplements for a ... unchanged, with
a very small decline of 0.01 ... baseline ?0.04?0.42 0.11?0.50 0.29?0.45 .01 ...
Frequently eating fish appears to slow memory loss in old age.
THE QUESTION: Does the amount of fish in the diet have an effect?
THIS STUDY analyzed dietary and medical data on 3,718 people ages 65 and older. Participants were given four standardized tests of cognition, and they were questioned periodically about the foods they ate. Over a six-year period, cognitive scores declined overall. Compared with those whose diets included no fish, scores dropped 10 percent more slowly for people who ate fish once a week and 13 percent more slowly for those who ate fish twice or more a week. The authors described this difference as equivalent to being three to four years younger.
WHO MAY BE AFFECTED BY THESE FINDINGS? Older people. About 15 percent of men and 11 percent of women over 65 have some degree of memory impairment.
CAVEATS: The study did not determine whether the benefit comes from the presence in fish of omega-3 fatty acids, which are key to brain development early in life.
FIND THIS STUDY: December issue of the Archives of Neurology; abstract available online at www.archneurol.com.
Following a heart attack, added arginine may pose a danger.
THE QUESTION: Blood vessels often become less pliable as people age, but the amino acid arginine — generally obtained in sufficient amounts through the diet — may help relieve this stiffness. Might over-the-counter arginine supplements benefit people with cardiovascular problems?
THIS STUDY randomly assigned 153 people older than 30 who recently had a heart attack for the first time to take arginine supplements or a placebo three times a day, along with their regular medications. After six months, standard measurements of heart functioning — including vascular stiffness and the amount of blood pumped out with each contraction of the left ventricle — revealed little difference between the groups. However, 17 percent of those taking arginine, compared with 10 percent of the placebo group, had another heart attack, were hospitalized for heart failure or died during this time. Six people (9 percent) taking the supplement had died; no one taking the placebo had died.
WHO MAY BE AFFECTED BY THESE FINDINGS? People with heart problems. Most people get sufficient amounts of arginine through their diet.
CAVEATS: The researchers intended to enroll roughly 300 participants, but the study was stopped early because of the number of people who died.
FIND THIS STUDY: Jan. 4 issue of the Journal of the American Medical Association; abstract available online at www.jama.com.
BREAST CANCER
When used first, letrozole may work better than tamoxifen.
THE QUESTION: A class of drugs called aromatase inhibitors has been shown to help women whose breast cancer does not respond to tamoxifen, the standard hormone treatment for cancers that require estrogen to grow. Might such a drug, which prevents estrogen from being produced, also prove beneficial if taken initially?
THIS STUDY randomly assigned 8,010 post-menopausal women with the type of early-stage breast cancer known as hormone-receptor-positive to take tamoxifen or letrozole (Femara) daily. After a little more than two years, cancer had recurred 19 percent less often among women taking letrozole than among those taking tamoxifen; the chance of its spreading to distant sites in the body was 27 percent less for the letrozole group. The study estimated that 84 percent of the letrozole group and 81 percent of the tamoxifen group would remain cancer-free for at least five years. Fractures, high cholesterol and serious heart problems were more common among women taking letrozole; blood clots, vaginal bleeding and endometrial cancer occurred more often in the tamoxifen group.
WHO MAY BE AFFECTED BY THESE FINDINGS? Women with hormone-receptor-positive breast cancer; 50 to 70 percent of all breast cancers are this type.
CAVEATS: A longer study would be needed to determine whether letrozole would continue to affect the relapse rate after treatment had stopped, as tamoxifen has been shown to do. The study was funded by Novartis, which makes Femara; company employees were members of a committee that reviewed the article, and seven of 14 primary authors had received consulting fees from Novartis.
FIND THIS STUDY Dec. 29 issue of the New England Journal of Medicine; abstract available online at www.nejm.org .
The research described in Quick Study comes from credible, peer-reviewed journals. Nonetheless, conclusive evidence about a treatment's effectiveness is rarely found in a single study. Anyone considering changing or beginning treatment of any kind should consult with a physician.
